Stockreport

Pfenex Receives U.S. FDA Approval for PF708 to Treat Osteoporosis

PFENEX INC  (PFNX) 
NASDAQ:AMEX Investor Relations: pfenex.com
PDF Pfenex earns a $2.5M milestone payment from Alvogen for U.S. approval Comparative human factors study report expected to be submitted to FDA as early as the second half [Read more]